Cite
MLA Citation
B. Alekseev et al.. “2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis.” European journal of cancer, vol. 51, n.d., pp. S518–S519. http://access.bl.uk/ark:/81055/vdc_100030628262.0x00005e